CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Ristan M. Greer

OPENALEX: A5014654181↗ORCID: 0000-0002-1574-4729↗

Affiliations

Organizations

Mater Researchauthorship · AU The University of Queenslandauthorship · AU

Public evidence

5 connected articles

Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol.2025 · Europe PMC Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.2024 · Europe PMC Exploring potential anti-inflammatory effects of medicinal cannabis.2023 · PubMed Central Open Access An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.2020 · Europe PMC Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD).2019 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Ristan M. Greer - Medical Cannabis Research Engine